Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
Yu‐Pei Chen(Sun Yat-sen University), Joseph Wee(SingHealth), Quynh‐Thu Le(Stanford University), Anne W.M. Lee(Chinese University of Hong Kong), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Jin‐Ching Lin(Changhua Christian Hospital), Junlin Yi(Chinese Academy of Medical Sciences & Peking Union Medical College), Nancy Y. Lee(Memorial Sloan Kettering Cancer Center), Jinyi Lang(University of Electronic Science and Technology of China), A. Dimitrios Colevas(Cancer Institute (WIA)), Melvin L.K. Chua(Duke-NUS Medical School), Ying Sun(Key Laboratory of Guangdong Province), Robert I. Haddad(Georgetown University), Sue S. Yom(University of California, San Francisco), Nofisat Ismaila(American Society of Clinical Oncology), Anthony T.�C. Chan(Chinese University of Hong Kong), Brigette Ma(Chinese University of Hong Kong), Shao Hui Huang(University of Toronto), Chaosu Hu(Ministry of Agriculture and Rural Affairs), T. J. Morgan, Alexander C. Whitley
Cited by 393
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k